Aron M. Knickerbocker

Aron M.
Knickerbocker currently works at Aulos Bioscience, Inc., as President, Chief Executive Officer & Director from 2021, KAHR Medical Ltd., as Chairman, and Phenomic AI, Inc., as Director.
Mr. Knickerbocker also formerly worked at Five Prime Therapeutics, Inc., as President, Chief Executive Officer & Director from 2018 to 2019, Rayzebio, Inc., as Chairman & Chief Executive Officer, ALZA Corp., as Director-Commercial Development from 2000 to 2001, Genentech, Inc., as Senior Director-Business Development from 2005 to 2009, Amgen, Inc., as Senior Manager-Corporate Development from 1996 to 2000, and Bristol Myers Squibb Co., as Scientist.
Mr. Knickerbocker received his undergraduate degree in 1990 from Washington University in St. Louis and Masters Business Admin degree in 1996 from the University of Michigan.